Infiximab for treatment of systemic amyloidosis associated with Crohn's disease

J Crohns Colitis. 2011 Apr;5(2):171-2. doi: 10.1016/j.crohns.2011.01.005. Epub 2011 Feb 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Amyloidosis / complications
  • Amyloidosis / drug therapy*
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Humans
  • Infliximab
  • Kidney Diseases / complications
  • Male

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Infliximab